Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Centers for Disease Control and Prevention [60Day-23-0666; Docket No. CDC-2023-0068]
 AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
 ACTION: Notice with comment period.
 SUMMARY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Healthcare Safety Network (NHSN). NHSN provides facilities, States, regions, and the nation with data necessary to identify problem areas, measure the progress of prevention efforts, and ultimately eliminate healthcare-associated infections (HAIs) nationwide.
 DATES: CDC must receive written comments on or before October 20, 2023.
 ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-0068 by either of the following methods: *Federal eRulemaking Portal: ww.regulations.gov.*
                         Follow the instructions for submitting comments.
                    *Mail:*
                         Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21-8, Atlanta, Georgia 30329. *Instructions:*
                         All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to 
                        *www.regulations.gov.* *Please note:*
                         Submit all comments through the Federal eRulemaking portal (
                        *www.regulations.gov*) or by U.S. mail to the address listed above.
 FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; Email: 
                        *omb@cdc.gov.*


SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the 
                    **Federal Register**
                     concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, 
                    *e.g.,*
                     permitting electronic submissions of responses; and 5. Assess information collection costs. Proposed Project National Healthcare Safety Network (NHSN) (OMB Control No. 0920-0666, Exp. 6/30/2026)—Revision—National Center for Emerging and Zoonotic Infection Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Division of Healthcare Quality Promotion (DHQP), National Center for Emerging and Zoonotic Infectious 
                    ( print page 56828)
                    Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) collects data from healthcare facilities in the National Healthcare Safety Network (NHSN) (OMB Control No. 0920-0666). NHSN provides facilities, States, regions, and the nation with data necessary to identify problem areas, measure the progress of prevention efforts, and ultimately eliminate healthcare-associated infections (HAIs) nationwide. NHSN allows healthcare facilities to track blood safety errors and various healthcare-associated infection prevention practice methods such as healthcare personnel influenza vaccine status and corresponding infection control adherence rates. NHSN currently has seven components: Patient Safety (PS), Healthcare Personnel Safety (HPS), Biovigilance (BV), Long-Term Care Facility (LTCF), Outpatient Procedure (OPC), Dialysis, and Neonatal Component. Data reported under the PS Component are used to determine the magnitude of the healthcare-associated adverse events and trends in the rates of the events, in the distribution of pathogens, and in the adherence to prevention practices. Data will help detect changes in the epidemiology of adverse events resulting from new medical therapies and changing patient risks. Additionally, reported data is being used to describe the epidemiology of antimicrobial use and resistance and to better understand the relationship of antimicrobial therapy to this rising problem. Under the HPS Component, protocols and data on events—both positive and adverse—are used to determine: (1) the magnitude of adverse events in healthcare personnel; and (2) compliance with immunization and sharps injuries safety guidelines. Under the BV Component, data on adverse reactions and incidents associated with blood transfusions are reported and analyzed to provide national estimates of adverse reactions and incidents. Under the LTCF Component, data is captured from skilled nursing facilities. Reporting methods under the LTCF component have been created by using forms from the PS Component as a model with modifications to specifically address the specific characteristics of LTCF residents and the unique data needs of these facilities reporting into NHSN. The Respiratory Tract Infection Form (RTI)—will not to be used by NHSN users, but as part of an EIP project with four EIP sites. The Form is titled 
                    *Denominators for Healthcare Associated Infections (HAIs): Respiratory Tract Infections.*
                     The purpose of this form is to allow testing prior to introducing a new module and forms to NHSN users. The CDC's Epidemiology Research & Innovations Branch (ERIB) team will use the form to perform field testing of variables to explore the utilization, applicability, and data collection burden associated with these variables. This process will inform areas of improvement prior to incorporating the new module, including protocol, forms, and instructions into NHSN. The Dialysis Component offers a simplified user interface for dialysis users to streamline their data entry and analysis processes as well as provide options for expanding in the future to include dialysis surveillance in settings other than outpatient facilities. The Outpatient Procedure Component (OPC) gathers data on the impact of infections and outcomes related to operative procedures performed in Ambulatory Surgery Centers (ASCs). The OPC is used to monitor two event types: Same Day Outcome Measures and Surgical Site Infections (SSIs). The Neonatal Component focuses on premature neonates and the healthcare associated events that occur as a result of their prematurity. This component currently has one module, which includes Late Onset-Sepsis and Meningitis. NHSN has increasingly served as the operating system for HAI reporting compliance through legislation established by the States. As of July 2023, 37 States, the District of Columbia and the City of Philadelphia, Pennsylvania have opted to use NHSN as their primary system for mandated reporting. Reporting compliance is completed by healthcare facilities in their respective jurisdictions, with emphasis on those States and municipalities acquiring varying consequences for failure to use NHSN. Additionally, healthcare facilities in five U.S. territories (Puerto Rico, American Samoa, the U.S. Virgin Islands, Guam, and the Northern Mariana Islands) are voluntarily reporting to NHSN. Additional territories are projected to follow with similar use of NHSN for reporting purposes. NHSN's data is used to aid in the tracking of HAIs and guide infection prevention activities/practices that protect patients. The Centers for Medicare and Medicaid Services (CMS) and other payers use these data to determine incentives for performance at healthcare facilities across the U.S. and surrounding territories, and members of the public may use some protected data to inform their selection among available providers. Each of these parties is dependent on the completeness and accuracy of the data. CDC and CMS work closely and are fully committed to ensuring complete and accurate reporting, which are critical for protecting patients and guiding national, State, and local prevention priorities. CMS collects some HAI data and healthcare personnel influenza vaccination summary data, which is done on a voluntary basis as part of its Fee-for-Service Medicare quality reporting programs, while others may report data required by a Federal mandate. Facilities that fail to report quality measure data are subject to partial payment reduction in the applicable Medicare Fee-for-Service payment system. CMS links their quality reporting to payment for Medicare-eligible acute care hospitals, inpatient rehabilitation facilities, long-term acute care facilities, oncology hospitals, inpatient psychiatric facilities, dialysis facilities, and ambulatory surgery centers. Facilities report HAI data and healthcare personnel influenza vaccination summary data to CMS via NHSN as part of CMS's quality reporting programs to receive full payment. Still, many healthcare facilities, even in States without HAI reporting legislation, submit limited HAI data to NHSN voluntarily. NHSN's data collection updates continue to support the incentive programs managed by CMS. For example, survey questions support requirements for CMS' quality reporting programs. Additionally, CDC has collaborated with CMS on a voluntary National Nursing Home Quality Collaborative, which focuses on recruiting nursing homes to report HAI data to NHSN and to retain their continued participation. The NHSN data collection was previously approved in June of 2023 for 6,209,922 responses and 1,693,215 annual burden hours. The proposed changes in this Revision include modifications to 15 existing data collection forms and one new form. CDC requests OMB approval for an estimated annual burden 1,524,039 hours. There is no cost to respondents other than their time to participate.
                    ( print page 56829) Estimated Annualized Burden Hours
Form number & name
Number of
                             respondents
Number of
                             responses per 
                             respondent
Average
                             burden per 
                             response 
                             (min./hour)
Total burden
                             (hours)57.100 NHSN Registration Form
2,000
1
5/60
16757.101 Facility Contact Information
2,000
1
10/60
33357.103 Patient Safety Component—Annual Hospital Survey
5,311
1
135/60
11,95057.104 Facility Administrator Change Request Form
800
1
5/60
6757.105 Group Contact Information
1,000
1
5/60
8357.106 Patient Safety Monthly Reporting Plan
6,387
12
15/60
19,16157.108 Primary Bloodstream Infection (BSI)
5,775
5
38/60
18,28857.111 Pneumonia (PNEU)
1,800
2
30/60
180057.112 Ventilator-Associated Event
5,463
8
28/60
20,39557.113 Pediatric Ventilator-Associated Event (PedVAE)
334
1
30/60
16757.114 Urinary Tract Infection (UTI)
6,000
5
20/60
10,00057.115 Custom Event
600
91
35/60
31,85057.116 Denominators for Neonatal Intensive Care Unit (NICU)
1,100
12
4/60
88057.117 Denominators for Specialty Care Area (SCA)/Oncology (ONC)
500
12
5/60
50057.118 Denominators for Intensive Care Unit (ICU)/Other locations (not NICU or SCA)
5,500
60
5/60
27,50057.120 Surgical Site Infection (SSI)
6,000
9
35/60
31,50057.121 Denominator for Procedure
6,000
602
10/60
602,00057.122 HAI Progress Report State Health Department Survey
55
1
28/60
2657.123 Antimicrobial Use and Resistance (AUR)-Microbiology Data Electronic Upload Specification Tables
5,500
12
5/60
5,50057.124 Antimicrobial Use and Resistance (AUR)-Pharmacy Data Electronic Upload Specification Tables
5,500
12
5/60
5,50057.125 Central Line Insertion Practices Adherence Monitoring
500
213
25/60
44,37557.126 MDRO or CDI Infection Form
720
11
30/60
3,96057.127 MDRO and CDI Prevention Process and Outcome Measures Monthly Monitoring
5,500
29
15/60
39,87557.128 Laboratory-identified MDRO or CDI Event
4,800
79
20/60
126,40057.129 Adult Sepsis
50
250
25/60
5,20857.135 Late Onset Sepsis/Meningitis Denominator Form: Data Table for monthly electronic upload
300
6
5/60
15057.136 Late Onset Sepsis/Meningitis Event Form: Data Table for Monthly Electronic Upload
300
6
5/60
15057.137 Long-Term Care Facility Component—Annual Facility Survey
17,700
1
122/60
35,99057.138 Laboratory-identified MDRO or CDI Event for LTCF
1,086
24
20/60
8,68857.139 MDRO and CDI Prevention Process Measures Monthly Monitoring for LTCF
1,019
12
20/60
4,07657.140 Urinary Tract Infection (UTI) for LTCF
339
36
35/60
7,11957.141 Monthly Reporting Plan for LTCF
1,099
12
15/60
3,29757.142 Denominators for LTCF Locations
714
12
35/60
4,99857.143 Prevention Process Measures Monthly Monitoring for LTCF
357
12
5/60
35757.150 LTAC Annual Survey
392
1
89/60
58157.151 Rehab Annual Survey
1,160
1
89/60
1,72157.200 Healthcare Personnel Safety Component Annual Facility Survey
50
1
480/60
40057.204 Healthcare Worker Demographic Data
50
200
20/60
3,33357.205 Exposure to Blood/Body Fluids
50
50
60/60
2,50057.206 Healthcare Worker Prophylaxis/Treatment
50
30
15/60
37557.207 Follow-Up Laboratory Testing
50
50
15/60
62557.210 Healthcare Worker Prophylaxis/Treatment-Influenza
50
50
10/60
41757.300 Hemovigilance Module Annual Survey
500
1
85/60
70857.301 Hemovigilance Module Monthly Reporting Plan
500
12
60/60
6,00057.303 Hemovigilance Module Monthly Reporting Denominators
500
12
70/60
7,00057.305 Hemovigilance Incident
500
10
10/60
83357.306 Hemovigilance Module Annual Survey—Non-acute care facility
500
1
35/60
29257.307 Hemovigilance Adverse Reaction—Acute Hemolytic Transfusion Reaction
500
4
20/60
66757.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction
500
4
20/60
66757.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction
500
1
20/60
16757.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction
500
2
20/60
33357.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic Transfusion Reaction
500
4
20/60
66757.312 Hemovigilance Adverse Reaction—Hypotensive Transfusion Reaction
500
1
20/60
16757.313 Hemovigilance Adverse Reaction—Infection
500
1
20/60
16757.314 Hemovigilance Adverse Reaction—Post Transfusion Purpura
500
1
20/60
16757.315 Hemovigilance Adverse Reaction—Transfusion Associated Dyspnea
500
1
20/60
16757.316 Hemovigilance Adverse Reaction—Transfusion Associated Graft vs. Host Disease
500
1
20/60
167( print page 56830)57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute Lung Injury
500
1
20/60
16757.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload
500
2
20/60
33357.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction
500
1
20/60
16757.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction
500
1
20/60
16757.400 Outpatient Procedure Component—Annual Facility Survey
350
1
10/60
11757.401 Outpatient Procedure Component—Monthly Reporting Plan
350
12
15/60
1,05057.402 Outpatient Procedure Component Same Day Outcome Measures
50
1
40/60
3357.403 Outpatient Procedure Component—Monthly Denominators for Same Day Outcome Measures
50
400
40/60
13,33357.404 Outpatient Procedure Component—SSI Denominator
300
100
10/60
5,00057.405 Outpatient Procedure Component—Surgical Site (SSI) Event
300
36
35/60
6,30057.500 Outpatient Dialysis Center Practices Survey
7,400
1
125/60
15,41757.501 Dialysis Monthly Reporting Plan
7,400
12
5/60
7,40057.502 Dialysis Event
7,400
30
27/60
99,90057.503 Denominator for Outpatient Dialysis
7,400
24
10/60
29,60057.504 Prevention Process Measures Monthly Monitoring for Dialysis
1,730
12
75/60
25,95057.505 Dialysis Patient Influenza Vaccination
615
50
10/60
5,12557.506 Dialysis Patient Influenza Vaccination Denominator
615
5
10/60
307557.507 Home Dialysis Center Practices Survey
450
1
36/60
270Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Non-Long-Term Care Facilities
125
52
60/60
6,500Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Long-Term Care Facilities
1,200
52
60/60
62,400Weekly Resident Influenza Vaccination Cumulative Summary for Long-Term Care Facilities
2,500
52
60/60
130,000Annual Healthcare Personnel Influenza Vaccination Summary
5,000
1
120/60
10,000Healthcare-facility onset, antibiotic-treated Clostridioides difficile (C. difficile) Infection (HT-CDI) Event Module Annual Reporting Plan
7,821
1
10/60
1,304Total Estimated Annual Burden Hours



1,524,039
 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention.


[FR Doc. 2023-17924 Filed 8-18-23; 8:45 am] BILLING CODE 4163-18-P